Results

Total Results: 48 records

Showing results for "considerations".

1. Feb-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
   January 01, 2017 - . · Discussion on LDL-c laboratory results to consider in the artifacts: · Considerations for timing … when considering lookback periods longer than 6 years and the specification needs to be practical. · Considerations … most recent. · Discussion on blood pressure (BP) measurement results to consider in the artifacts: · Considerations … The WG members offered several considerations on the merits of different interventions and considerations … artifact design decisions to implementers and users While discussing specific implications of design considerations

2. Recommendation #8: Naloxone Consideration | CDS Connect
   cds.ahrq.gov/cdsconnect/artifact/recommendation-8-naloxone-consideration
   September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

3. Aug-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/251/aug-2017-cholesterol-wg-notes.docx
   January 01, 2017 - information would be best incorporated in to the Implementation Guide, nearby by the other clinical considerations … encouraged to view the Repository and provide feedback as they navigate around the different tabs (i.e., considerations

4. Title of document or resource (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
   January 01, 2017 - , specification of conditions, lookback periods and the inclusion of parameters for scalar values · Considerations … disease: · Consider allergy as additional exclusion. · Consider using aspirin 81mg as “default” dose. · Considerations

5. March 2022 CDS Connect Work Group Presentation (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Presentation.pdf
   January 01, 2022 - Subsequent updates to version numbers should be coordinated with the CDS Connect project team, with these considerations … original intent) ► The underlying evidence has significantly changed or been replaced • Discussion considerations

6. March 2022 CDS Connect Work Group Summary (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
   January 01, 2022 - possibility of creating two separate artifacts with different functions—one for positive prescribing considerations … With these considerations, MITRE decided to rename the artifact, yet continue the previous version

7. Jul-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
   January 01, 2017 - the status of the USPSTF Statin Use artifact results during AllianceChicago(AC) pilot, discussed new considerations … ALT Lab Test Considerations The CAMH team needs to create a value set to represent ALT lab tests since

8. AHRQ PCOR CDS Project Kickoff (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
   July 23, 2024 - – Non-opioid medications – Non-pharmacologic treatments – Stool softeners and laxatives Risk Considerations … Distribution Only—Not for Public Release List of Flags Implemented in the Summary Interface – Part 2 Risk Considerations

9. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
   January 01, 2024 - ................................................................. 8 Patient-Facing CDS Development Considerations … CDS Artifacts ............................................ 9 Patient Notification and Intervention Considerations … pilot partner, b.well, are displayed in this document in the Patient Notification and Intervention Considerations … Patient-Facing CDS Development Considerations Patients and their caregivers are increasingly seeking … Patient Notification and Intervention Considerations For any patient who qualifies for the recommended

10. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - ................................................................. 8 Patient-Facing CDS Development Considerations … Care CDS Artifacts .......................................... 10 Patient Notification and Intervention Considerations … pilot partner, b.well, are displayed in this document in the Patient Notification and Intervention Considerations … Patient-Facing CDS Development Considerations Patients and their caregivers are increasingly seeking … Patient Notification and Intervention Considerations For any patient who qualifies for the recommended

11. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - ................................................................. 8 Patient-Facing CDS Development Considerations … Care CDS Artifacts .......................................... 10 Patient Notification and Intervention Considerations … Patient Notification and Intervention Considerations For any patient who qualifies for the recommended … WG members provided guidance on translation of the recommendation statement, raised considerations to … WG members provided guidance on translation of the recommendation statement, raised considerations to

12. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - ................................................................. 8 Patient-Facing CDS Development Considerations … Care CDS Artifacts .......................................... 10 Patient Notification and Intervention Considerations … Patient Notification and Intervention Considerations For any patient who qualifies for the recommended … WG members provided guidance on translation of the recommendation statement, raised considerations to … WG members provided guidance on translation of the recommendation statement, raised considerations to

13. April 2022 CDS Connect Work Group Call (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Presentation.pdf
    January 01, 2022 - Early and continued patient involvement • COVID challenges and new virtual opportunities • Important considerations

14. Clostridium Difficile (C.Diff) Infection Treatment Pathway Updated March 2019 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
    January 01, 1970 - Pathway inclusion criteria: Inpatient, confirmed or high suspicion of C. difficile infection (CDI) Non-fulminant Determine if CDI is fulminant If possible, STOP precipitating antibiotic(s), laxatives, acid-suppression agents, anti-peristaltic agents CDI recurrence? Significant Abdominal Findings? NO significant …

15. Jan-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - . · The WG also offered considerations surrounding the provision of medication recommendations based

16. Implementation Guide: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - ................................................................. 8 Patient-Facing CDS Development Considerations … CDS Artifacts ............................................ 9 Patient Notification and Intervention Considerations … organizational preferences, patient population, and available resources. 9 Patient-Facing CDS Development Considerations … Patient Notification and Intervention Considerations For any patient who qualifies for the recommended … Development of Patient-Centered Preventive Care CDS Artifacts Patient Notification and Intervention Considerations

17. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - Cholesterol Management Work Group Meeting Summary Date 12/09/16 Time 2:00 – 4:00 PM EST AGENDA · Welcome and Introductions · CDS Connect Project Overview · CDS Cholesterol Management Work Group Overview and Planning · CDS Cholesterol Management Environmental Scan Findings and Artifacts · CDS Cho…

18. CAMH Long Doc Template (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - Panel Meetings on Prevention and Treatment of Anthrax in Adults: Technical Appendix [6] • Special Considerations … for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women [7] • Special Considerations … Bryn Rhodes LICENSES.txt Describes intellectual property considerations for each CQL/ELM file. … [7] Meanye-Delman D. et al., "Special Considerations for Prophylaxis for and Treatment of Anthrax … [8] Meaney-Delman D. et al., "Special Considerations for Prophylaxis for and Treatment of Anthrax

19. CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - Pain Management Summary – Risk Considerations ..................................................... 21 … sections: Pertinent Medical History, Pain Assessments, Historical Pain-related Treatments, and Risk Considerations … nl ,_,:, Risk Considerations (7) o Most Recent MME O NRme ; MOConsiderations Pain Management Summary Enhancements Artifact Enhancements … integration with the State PDMP, but because of the variation of technical capabilities as well as legal considerations

20. Apr-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Some eCQM items, like Hepatitis A and B, are lesser considerations and don’t need to be included. · Diagnosis